Literature DB >> 24551410

Inter-rater agreement among physicians on the clinical significance of drug-drug interactions.

Howard R Strasberg1, Albert Chan2, Stephen J Sklar1.   

Abstract

BACKGROUND: Alert fatigue could potentially be improved if physicians agreed on which alerts were clinically significant. We conducted a study to determine the extent to which physicians agree on which drug-drug interactions are clinically significant.
METHODS: Two groups of eight generalist physicians reviewed 100 randomly selected drug-drug interactions from the Medi-Span® Drug Therapy Monitoring System™ database and indicated whether they thought each interaction was clinically significant based on the full-text clinical discussion contained within each interaction monograph and their clinical experience.
RESULTS: The Fleiss Kappa measure of inter-rater agreement was 0.19 (0.12, 0.26) for one group, 0.22 (0.14, 0.29) for the second group and 0.21 (0.15, 0.27) for the combined group.
CONCLUSION: We found poor agreement among generalist physicians on which drug-drug interactions are clinically significant. Use of a feature to allow physicians to tailor alerts to their needs may be an important component in reducing alert fatigue.

Entities:  

Mesh:

Year:  2013        PMID: 24551410      PMCID: PMC3900147     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  6 in total

1.  High-priority drug-drug interactions for use in electronic health records.

Authors:  Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2012-04-26       Impact factor: 4.497

2.  Overriding of drug safety alerts in computerized physician order entry.

Authors:  Heleen van der Sijs; Jos Aarts; Arnold Vulto; Marc Berg
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

3.  Computing inter-rater reliability and its variance in the presence of high agreement.

Authors:  Kilem Li Gwet
Journal:  Br J Math Stat Psychol       Date:  2008-05       Impact factor: 3.380

4.  Frequency and nature of drug-drug interactions in a Dutch university hospital.

Authors:  Jeannette E F Zwart-van Rijkom; Esther V Uijtendaal; Maarten J ten Berg; Wouter W van Solinge; Antoine C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

5.  Alert fatigue.

Authors:  Jared J Cash
Journal:  Am J Health Syst Pharm       Date:  2009-12-01       Impact factor: 2.637

6.  Measuring the effects of reminders for outpatient influenza immunizations at the point of clinical opportunity.

Authors:  P C Tang; M P LaRosa; C Newcomb; S M Gorden
Journal:  J Am Med Inform Assoc       Date:  1999 Mar-Apr       Impact factor: 4.497

  6 in total
  5 in total

1.  Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.

Authors:  S M M Meslin; W Y Zheng; R O Day; E M Y Tay; M T Baysari
Journal:  Appl Clin Inform       Date:  2018-11-28       Impact factor: 2.342

Review 2.  Modulators Influencing Medication Alert Acceptance: An Explorative Review.

Authors:  Janina A Bittmann; Walter E Haefeli; Hanna M Seidling
Journal:  Appl Clin Inform       Date:  2022-08-18       Impact factor: 2.762

3.  A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators.

Authors:  Jan Schjøtt; Jörg Aßmus
Journal:  BMC Med Inform Decis Mak       Date:  2019-05-29       Impact factor: 2.796

4.  Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.

Authors:  Anna Somogyi-Végh; Zsófia Ludányi; Ábel Erdős; Lajos Botz
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-31       Impact factor: 2.483

5.  Development and Validation of a Standardized Tool for Prioritization of Information Sources.

Authors:  Holy Akwar; Harold Kloeze; Shamir Mukhi
Journal:  Online J Public Health Inform       Date:  2016-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.